Evidence map›Paper›PMID 39131017›Full record

ArticleCureus2024

Factors Associated With Ambulation Status and Survival One Year After Conservative Management of Hip Fracture.

Keisuke Nakamura, Tomohiro Sasaki, Marin Yokoyama, Takashi Kitagawa, Yuto Akashi, Masayuki Shimizu

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Keisuke NakamuraDepartment of Physical Therapy, Shinshu University, Matsumoto, JPN.
Tomohiro SasakiDepartment of Rehabilitation, Matsumoto City Hospital, Matsumoto, JPN.
Marin YokoyamaDepartment of Rehabilitation, Matsumoto City Hospital, Matsumoto, JPN.
Takashi KitagawaDepartment of Physical Therapy, Shinshu University, Matsumoto, JPN.
Yuto AkashiDepartment of Physical Therapy, Shinshu University, Matsumoto, JPN.
Masayuki ShimizuDepartment of Orthopedics, Matsumoto City Hospital, Matusmoto, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFew studies have investigated the factors associated with ambulation and survival over one year. Therefore, this study aimed to examine the factors that influence ambulation and survival rates in elderly patients who have undergone conservative management for hip fractures. MATERIALS AND

methodsThis retrospective study included 74 ambulatory individuals aged 65 years or older prior to their injuries. One-year mortality and ambulatory status were assessed. Statistical comparisons of background and medical characteristics between groups of independent and non-independent walkers, as well as between survivors and mortalities, were performed using the Pearson chi-squared, Fisher exact, and Mann-Whitney U tests.

resultsThe numbers of older patients able to walk independently, those not able to walk independently, and those with mortality at one-year post-injury after conservative management of hip fractures were 13 (18.3%), 35 (49.3%), and 23 (32.4%), respectively. Independent walkers one year after conservative treatment for hip fracture were younger (p=0.04) and less likely to have cognitive impairment (p=0.04) than non-independent walkers. The proportion of individuals with cognitive impairment was found to be lower among survivors than among mortalities (p=0.0098).

conclusionCognitive decline may contribute to difficulties in walking independently and mortality at one year post-injury in this population.

Indexed as

conservative treatmenthip fractureindependent walkermortalityolder patients

Identifiers

PMID39131017
PMCPMC11314690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.